[go: up one dir, main page]

CN106619149A - Method for preparing nicotinamide-coated multivesicular liposomes - Google Patents

Method for preparing nicotinamide-coated multivesicular liposomes Download PDF

Info

Publication number
CN106619149A
CN106619149A CN201710050472.1A CN201710050472A CN106619149A CN 106619149 A CN106619149 A CN 106619149A CN 201710050472 A CN201710050472 A CN 201710050472A CN 106619149 A CN106619149 A CN 106619149A
Authority
CN
China
Prior art keywords
amino acid
osmotic pressure
organic solvent
pressure regulator
niacinamide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201710050472.1A
Other languages
Chinese (zh)
Inventor
张婉萍
李玲玉
欧文华
朱海洋
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shanghai Institute of Technology
Original Assignee
Shanghai Institute of Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shanghai Institute of Technology filed Critical Shanghai Institute of Technology
Priority to CN201710050472.1A priority Critical patent/CN106619149A/en
Publication of CN106619149A publication Critical patent/CN106619149A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/14Liposomes; Vesicles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/55Phosphorus compounds
    • A61K8/553Phospholipids, e.g. lecithin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63Steroids; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67Vitamins
    • A61K8/673Vitamin B group
    • A61K8/675Vitamin B3 or vitamin B3 active, e.g. nicotinamide, nicotinic acid, nicotinyl aldehyde
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/10General cosmetic use
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/41Particular ingredients further characterized by their size
    • A61K2800/412Microsized, i.e. having sizes between 0.1 and 100 microns

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)

Abstract

一种包覆烟酰胺的多囊泡脂质体,由磷脂、中性脂质、胆固醇、有机溶剂、亲水性乳化剂、烟酰胺、氨基酸、渗透压调节剂和去离子水组成。本发明将磷脂、胆固醇和中性脂质溶于有机溶剂中,作为有机相;将烟酰胺、氨基酸、渗透压调节剂和去离子水混合均匀作为内水相;均质有机相组分,将内水相组分加入,制得W/O型初乳液;将亲水性乳化剂、氨基酸、渗透压调节剂和去离子水混合,分散作为外水相;均质外水相组分,加入W/O型初乳液组分,均质后进行超声,再搅拌冷却至室温,形成W/O/W型多重乳液;再将多重乳液分散于氨基酸溶液中,通入氮气除去有机溶剂,即得包覆烟酰胺的多囊泡脂质体悬浮液。本发明提高了烟酰胺的稳定性。

A multivesicle liposome coated with nicotinamide is composed of phospholipid, neutral lipid, cholesterol, organic solvent, hydrophilic emulsifier, nicotinamide, amino acid, osmotic pressure regulator and deionized water. In the present invention, phospholipids, cholesterol and neutral lipids are dissolved in an organic solvent as an organic phase; nicotinamide, amino acid, osmotic pressure regulator and deionized water are uniformly mixed as an internal water phase; the homogeneous organic phase components are The inner water phase components are added to prepare W/O type primary emulsion; the hydrophilic emulsifier, amino acid, osmotic pressure regulator and deionized water are mixed and dispersed as the outer water phase; the homogeneous outer water phase components are added The W/O type primary emulsion components are homogenized, ultrasonicated, then stirred and cooled to room temperature to form a W/O/W type multiple emulsion; then the multiple emulsion is dispersed in the amino acid solution, and nitrogen gas is introduced to remove the organic solvent to obtain Suspension of multivesicular liposomes coated with niacinamide. The invention improves the stability of nicotinamide.

Description

一种包覆烟酰胺的多囊泡脂质体的制备方法A preparation method of multivesicular liposomes coated with nicotinamide

技术领域technical field

本发明属于化妆品领域,涉及一种脂质体,具体来说是一种包覆烟酰胺的多囊泡脂质体及其制备方法。The invention belongs to the field of cosmetics and relates to a liposome, in particular to a multivesicle liposome coated with nicotinamide and a preparation method thereof.

背景技术Background technique

烟酰胺是维生素B3的一种衍生物,是一种多功能活性物,近年来越来越为人们所重视,其具有6大护肤功效:美白、抗衰老、改善皮肤屏障功能、保湿、控油与缩小毛孔、治疗痤疮。因此,其在化妆品中的应用涉及到美白产品、祛皱产品、润肤产品、祛痘产品、洗护发产品。但烟酰胺对pH非常敏感,稳定性差,其在pH值高于或低于6的溶液中,会水解形成烟酸,造成皮肤过敏;此外,烟酰胺在潮热的环境下表现出较明显的结块性,储存过程中稳定性差,因此限制了烟酰胺在化妆品中的广泛使用。Niacinamide, a derivative of vitamin B3, is a multifunctional active substance that has attracted more and more attention in recent years. It has 6 major skin care effects: whitening, anti-aging, improving skin barrier function, moisturizing, oil control and Shrink pores, treat acne. Therefore, its application in cosmetics involves whitening products, anti-wrinkle products, moisturizing products, anti-acne products, and hair care products. However, nicotinamide is very sensitive to pH and has poor stability. In a solution with a pH value higher or lower than 6, it will be hydrolyzed to form nicotinic acid, causing skin allergies; Caking and poor stability during storage, thus limiting the widespread use of niacinamide in cosmetics.

多囊脂质体(multivesieularliposomes,MVLs),又称多囊泡脂质体,是一种结构特殊的新型脂质体制剂,其不连续的水性内腔被非同心的类脂以及磷脂膜所分隔,形成许多细微的囊泡。MVLS颗粒呈蜂巢状,粒径大小一般在1-100μm之间。MVLs多囊泡的结构使其具有更多的水溶性物质包封容积,水室体积占颗粒总体积的95%,其水溶性物质的载活性物量比传统的单层脂质体和多层脂质体要高得多;当某个囊泡破裂时,活性物质从破裂囊泡释出,完整的囊泡仍然可以保持原状,因而有很好的缓释效应;脂质层的非同心结构使脂质体的稳定性增加,且活性物的释放时间延长。Multivesicular liposomes (MVLs), also known as multivesicular liposomes, are a new type of liposome preparation with a special structure, and its discontinuous aqueous lumen is separated by non-concentric lipid and phospholipid membranes. , forming many tiny vesicles. MVLS particles are honeycomb-shaped, and the particle size is generally between 1-100 μm. The structure of MVLs multivesicles makes it have more encapsulating volume of water-soluble substances, and the volume of the water chamber accounts for 95% of the total particle volume. The plastid is much higher; when a vesicle ruptures, the active substance is released from the ruptured vesicle, and the intact vesicle can still maintain its original shape, so it has a good slow-release effect; the non-concentric structure of the lipid layer makes The stability of the liposome is increased, and the release time of the active substance is prolonged.

对于亲水性物质的包覆需要借助于多囊泡脂质体,将烟酰胺包覆于内水相,形成一种针对于烟酰胺的包覆载体结构。以提高烟酰胺的稳定性、减小刺激性,进而提高烟酰胺的活性和应用广泛性。For the coating of hydrophilic substances, multivesicular liposomes are needed to coat nicotinamide in the inner water phase to form a coating carrier structure for nicotinamide. To improve the stability of nicotinamide, reduce the irritation, and then improve the activity and wide application of nicotinamide.

目前,关于多囊泡脂质体载体技术的研究已经有很多,多为包覆药物应用于医疗行业,其制备工艺较复杂,但包覆烟酰胺的多囊泡脂质体并将其应用于化妆品中的尚未见公开。At present, there have been many studies on multivesicular liposome carrier technology, most of which are coated drugs used in the medical industry. The preparation process is relatively complicated, but multivesicular liposomes coated with nicotinamide and applied to Cosmetics have not yet been published.

发明内容Contents of the invention

针对现有技术中的上述技术问题,本发明提供了一种包覆烟酰胺的多囊泡脂质体及其制备方法,所述的这种包覆烟酰胺的多囊泡脂质体及其制备方法要解决现有技术中的烟酰胺定性差的技术问题。Aiming at the above-mentioned technical problems in the prior art, the present invention provides a multivesicular liposome coated with nicotinamide and a preparation method thereof, the multivesicular liposome coated with nicotinamide and its preparation method The preparation method should solve the technical problem of poor quality of nicotinamide in the prior art.

本发明提供了一种包覆烟酰胺的多囊泡脂质体,按重量百分比计算,其原料组成及含量如下:The invention provides a multivesicular liposome coated with nicotinamide. The composition and content of the raw materials are as follows:

磷脂 1.0~20.0%;Phospholipids 1.0~20.0%;

中性脂质 1.0~10.0%;Neutral lipid 1.0~10.0%;

胆固醇 1.0~10.0%;Cholesterol 1.0~10.0%;

有机溶剂 5.0~20.0%;Organic solvent 5.0~20.0%;

烟酰胺 0.01~5.0%;Niacinamide 0.01~5.0%;

亲水性乳化剂 0.1~12.0%;Hydrophilic emulsifier 0.1~12.0%;

氨基酸 0.1~1.0%;Amino acid 0.1~1.0%;

渗透压调节剂 2.0~8.0%;Osmotic pressure regulator 2.0~8.0%;

去离子水 余量;Deionized water balance;

所述的磷酸为卵磷脂、氢化卵磷脂、大豆磷脂、磷脂酰乙醇胺、二硬脂酰磷脂酰胆碱、二肉豆蔻酰磷脂酰胆碱、二油酰磷脂酰乙醇胺、或者二棕榈酰磷脂酰甘油中的一种或两种以上所组成的混合物;The phosphoric acid is lecithin, hydrogenated lecithin, soybean lecithin, phosphatidylethanolamine, distearoylphosphatidylcholine, dimyristoylphosphatidylcholine, dioleoylphosphatidylethanolamine, or dipalmitoylphosphatidylcholine One or a mixture of two or more glycerin;

所述的中性脂质为三油酸甘油酯、甘油酸、月桂酸甘油酯、三癸酸甘油酯、三辛酸甘油酯、或者维生素E中的一种或两种以上所组成的混合物;The neutral lipid is glyceryl trioleate, glyceric acid, glyceryl laurate, glyceryl tricaprate, glyceryl tricaprylate, or one or a mixture of two or more of vitamin E;

所述的有机溶剂为乙醚、乙醇、丁醇、或者乙酸乙酯中的一种或两种以上所组成的混合物;The organic solvent is one or a mixture of ether, ethanol, butanol, or ethyl acetate;

所述的亲水性乳化剂为吐温80、聚氧乙烯-聚氧丙烯嵌段共聚物、肽类双分子亲油亲水表活、PEG-100硬脂酸酯、甘油硬脂酸酯、花生醇和山嵛醇和花生醇葡糖苷、鲸蜡硬脂醇和鲸蜡硬脂基葡糖苷、脂肪醇聚氧乙烯醚(21EO)、山嵛酸甘油酯、或者鲸蜡硬脂基葡糖苷中的一种或两种以上所组成的混合物;The hydrophilic emulsifier is Tween 80, polyoxyethylene-polyoxypropylene block copolymer, peptide bimolecular lipophilic and hydrophilic surfactant, PEG-100 stearate, glycerol stearate, One of arachidyl alcohol and behenyl alcohol and arachidyl alcohol glucoside, cetearyl alcohol and cetearyl glucoside, fatty alcohol polyoxyethylene ether (21EO), glyceryl behenate, or cetearyl glucoside A mixture of two or more kinds;

所述的氨基酸为赖氨酸、天门冬氨酸、丝氨酸、L-精氨酸、丙氨酸、门冬氨酸、谷氨酸、甘氨酸、组氨酸、色氨酸、酪氨酸、脯氨酸、亮氨酸、或者缬氨酸中的一种或两种以上的混合物;Described amino acid is lysine, aspartic acid, serine, L-arginine, alanine, aspartic acid, glutamic acid, glycine, histidine, tryptophan, tyrosine, proline One or a mixture of two or more of amino acid, leucine, or valine;

所述的渗透压调节剂为葡萄糖、蔗糖、或者生理盐水中的一种或两种以上的混合物。The osmotic pressure regulator is one or a mixture of glucose, sucrose, or physiological saline.

进一步的,上述的一种包覆烟酰胺的多囊泡脂质体,按重量百分比计算,其原料组成及含量如下:Further, the above-mentioned multivesicular liposome coated with nicotinamide has the following raw material composition and content in terms of weight percentage:

磷脂 1.0%;Phospholipids 1.0%;

中性脂质 1.0%;Neutral Lipid 1.0%;

胆固醇 1.0%;Cholesterol 1.0%;

有机溶剂 5.0%;Organic solvent 5.0%;

烟酰胺 0.01%;Niacinamide 0.01%;

亲水性乳化剂 0.1%;Hydrophilic emulsifier 0.1%;

氨基酸 0.1%;Amino acid 0.1%;

渗透压调节剂 2.0%;Osmotic pressure regulator 2.0%;

去离子水 余量;Deionized water balance;

所述的磷脂为卵磷脂;Described phospholipid is lecithin;

所述的中性油脂为三油酸甘油酯;Described neutral fat is glyceryl trioleate;

所述的有机溶剂为乙醚;Described organic solvent is ether;

所述的亲水性乳化剂为吐温80;Described hydrophilic emulsifier is Tween 80;

所述的氨基酸为赖氨酸;Described amino acid is lysine;

所述的渗透压调节剂为葡萄糖。The osmotic pressure regulator is glucose.

进一步的,上述的一种包覆烟酰胺的多囊泡脂质体,按重量百分比计算,其原料组成及含量如下:Further, the above-mentioned multivesicular liposome coated with nicotinamide has the following raw material composition and content in terms of weight percentage:

磷脂 10.0%;Phospholipids 10.0%;

中性脂质 5.0%;Neutral lipid 5.0%;

胆固醇 5.0%;Cholesterol 5.0%;

有机溶剂 12.5%;Organic solvent 12.5%;

烟酰胺 2.5%;Niacinamide 2.5%;

亲水性乳化剂 6.0%;Hydrophilic emulsifier 6.0%;

氨基酸 0.5%;Amino acid 0.5%;

渗透压调节剂 5.0%;Osmotic pressure regulator 5.0%;

去离子水 余量;Deionized water balance;

所述的磷脂为氢化卵磷脂、或者大豆卵磷脂中的一种或两种组成的混合物;The phospholipid is one or a mixture of hydrogenated lecithin or soybean lecithin;

所述的中性物质为甘油酸;Described neutral substance is glyceric acid;

所述的有机溶剂为乙醇;Described organic solvent is ethanol;

所述的亲水性乳化剂为聚氧乙烯-聚氧丙烯嵌段共聚物、或者PEG-100硬脂酸酯中的一种或两种所组成的混合物;The hydrophilic emulsifier is a polyoxyethylene-polyoxypropylene block copolymer or a mixture of one or two of PEG-100 stearate;

所述的氨基酸为天门冬氨酸;The amino acid is aspartic acid;

所述的渗透压调节剂为蔗糖。The osmotic pressure regulator is sucrose.

进一步的,上述的一种包覆烟酰胺的多囊泡脂质体,按重量百分比计算,其原料组成及含量如下:Further, the above-mentioned multivesicular liposome coated with nicotinamide has the following raw material composition and content in terms of weight percentage:

磷脂 20.0%Phospholipids 20.0%

中性脂质 10.0%;Neutral Lipid 10.0%;

胆固醇 10.0%;Cholesterol 10.0%;

有机溶剂 20.0%;Organic solvent 20.0%;

烟酰胺 5.0%;Niacinamide 5.0%;

亲水性乳化剂 12.0%;Hydrophilic emulsifier 12.0%;

氨基酸 1.0%;Amino acid 1.0%;

渗透压调节剂 8.0%;Osmotic pressure regulator 8.0%;

去离子水 余量;Deionized water balance;

所述的磷酸为磷脂酰乙醇胺;Described phosphoric acid is phosphatidylethanolamine;

所述的中性脂质为三辛酸甘油酯、维生素E中的一种或两种所组成的混合物;The neutral lipid is one or a mixture of tricaprylin and vitamin E;

所述的有机溶剂为丁醇;Described organic solvent is butanol;

所述的亲水性乳化剂为肽类双分子亲油亲水表活、鲸蜡硬脂醇和鲸蜡硬脂基葡糖苷中的一种或两种所组成的混合物;The hydrophilic emulsifier is a mixture of one or two of peptide bimolecular lipophilic and hydrophilic surfactants, cetearyl alcohol and cetearyl glucoside;

所述的氨基酸为L-精氨酸;The amino acid is L-arginine;

所述的渗透压调节剂为生理盐水。The osmotic pressure regulator is physiological saline.

本发明还提供了上述的一种包覆烟酰胺的多囊泡脂质体的制备方法,包括以下步骤:The present invention also provides the above-mentioned preparation method of multivesicular liposomes coated with nicotinamide, comprising the following steps:

1)按重量百分比称取磷脂、中性脂质、胆固醇、有机溶剂、亲水性乳化剂、烟酰胺、氨基酸、渗透压调节剂和去离子水;1) Weighing phospholipids, neutral lipids, cholesterol, organic solvents, hydrophilic emulsifiers, nicotinamide, amino acids, osmotic pressure regulators and deionized water by weight percentage;

2)将磷脂、胆固醇和中性脂质溶于有机溶剂中,作为有机相;2) dissolving phospholipids, cholesterol and neutral lipids in an organic solvent as an organic phase;

3)配置1~100mmol/L的氨基酸溶液,将烟酰胺、30~60%的氨基酸溶液、30~60%的渗透压调节剂和30~60%的去离子水混合,作为内水相;3) Prepare 1~100mmol/L amino acid solution, mix nicotinamide, 30~60% amino acid solution, 30~60% osmotic pressure regulator and 30~60% deionized water as the inner water phase;

4)将步骤3)中所得内水相加入有机相中,以均质速度7200~30000rpm均质有机相组分,同时将内水相组分加入其中,均质1~15min,制得W/O型初乳液;4) Add the internal water phase obtained in step 3) into the organic phase, homogenize the organic phase components at a homogenization speed of 7200-30000rpm, and simultaneously add the internal water phase components, homogenize for 1-15min, and obtain W/ O-type primary emulsion;

5)将亲水性乳化剂、剩余含量的氨基酸溶液、剩余含量的渗透压调节剂和剩余含量的去离子水的混合,作为外水相;5) mixing the hydrophilic emulsifier, the remaining content of the amino acid solution, the remaining content of the osmotic pressure regulator and the remaining content of deionized water as the external water phase;

6)以均质速度7200~30000rpm均质外水相组分,同时将步骤(3)制得的W/O型初乳液组分加入其中,均质1~15min后,选择超声功率20%~30%,超声5秒停止5秒,对乳状液超声1~20min,搅拌至体系均一并自然冷却降至室温,制成W/O/W型多重乳液;6) Homogenize the outer water phase components at a homogenization speed of 7200-30000rpm, and at the same time add the W/O-type primary emulsion components prepared in step (3) to it. After homogenizing for 1-15 minutes, select the ultrasonic power of 20%- 30%, ultrasonication for 5 seconds and stop for 5 seconds, ultrasonication of the emulsion for 1 to 20 minutes, stirring until the system is uniform and cooled down to room temperature naturally to make a W/O/W multiple emulsion;

7)配置与步骤3)中浓度相同的氨基酸溶液,将得到的多重乳液分散于氨基酸溶液中,其中多重乳液与氨基酸溶液的体积比为5:1~1:5,通入氮气除去多重乳液中的有机溶剂,制得包覆烟酰胺的多囊泡脂质体悬浮液。7) Configure the amino acid solution with the same concentration as in step 3), disperse the obtained multiple emulsion in the amino acid solution, wherein the volume ratio of the multiple emulsion to the amino acid solution is 5:1 to 1:5, and pass nitrogen gas to remove the multiple emulsion Organic solvent, prepared multivesicular liposome suspension coated with nicotinamide.

该步骤7)中的氨基酸溶液的作用是影响水溶液的pH,调节油水界面磷脂的表面电荷,提高多囊泡脂质体的静电稳定性,减少多囊泡脂质体在氮吹除去有机溶剂过程中的破乳现象,并不参与多囊泡脂质体的形成过程,因此配方中氨基酸的含量并不包括此部分。The effect of the amino acid solution in this step 7) is to affect the pH of the aqueous solution, regulate the surface charge of the oil-water interface phospholipid, improve the electrostatic stability of the multivesicular liposome, and reduce the removal of the organic solvent process of the multivesicular liposome by nitrogen blowing The demulsification phenomenon in the formula does not participate in the formation process of multivesicular liposomes, so the content of amino acids in the formula does not include this part.

本发明将磷脂、胆固醇和中性脂质溶于有机溶剂中,作为有机相;将烟酰胺、氨基酸、渗透压调节剂和去离子水混合均匀作为内水相;均质有机相组分,将内水相组分加入,制得W/O型初乳液;将亲水性乳化剂、氨基酸、渗透压调节剂和去离子水混合,分散均匀作为外水相;均质外水相组分,加入之前制备的W/O型初乳液组分,均质后进行超声,再搅拌冷却至室温,形成W/O/W型多重乳液;再将多重乳液分散于氨基酸溶液中,通入氮气除去多重乳液中的有机溶剂,即得包覆烟酰胺的多囊泡脂质体悬浮液。In the present invention, phospholipids, cholesterol and neutral lipids are dissolved in an organic solvent as an organic phase; nicotinamide, amino acid, osmotic pressure regulator and deionized water are uniformly mixed as an internal water phase; the homogeneous organic phase components are The inner water phase components are added to prepare the W/O type primary emulsion; the hydrophilic emulsifier, amino acid, osmotic pressure regulator and deionized water are mixed and dispersed evenly as the outer water phase; the homogeneous outer water phase components, Add the previously prepared W/O-type primary emulsion components, homogenize and perform ultrasonication, then stir and cool to room temperature to form a W/O/W-type multiple emulsion; then disperse the multiple emulsions in the amino acid solution, and pass through nitrogen to remove multiple emulsions. The organic solvent in the emulsion obtains the multivesicular liposome suspension coated with nicotinamide.

本发用了适宜的磷脂、中性脂质、胆固醇、有机溶剂、氨基酸、渗透压调节剂和去离子水的复配方案。制备过程中采用两步乳化法,并且进行超声,因此,最终所得的多囊泡脂质体的分散相粒子的粒径较均一,并且其制备工艺简单、能耗低,形成的乳液体系稳定,不仅给烟酰胺提供了合适的载体,提高了烟酰胺的稳定性,降低了其对皮肤的刺激性,对皮肤温和,吸收快, 兼具功能性和美容性。In the present invention, a compounding scheme of suitable phospholipids, neutral lipids, cholesterol, organic solvents, amino acids, osmotic pressure regulators and deionized water is used. Adopt two-step emulsification method in the preparation process, and carry out ultrasonic, therefore, the particle diameter of the dispersed phase particle of the multivesicular liposome of final gained is relatively uniform, and its preparation process is simple, energy consumption is low, and the emulsion system formed is stable, It not only provides a suitable carrier for niacinamide, improves the stability of niacinamide, reduces its irritation to the skin, is mild to the skin, absorbs quickly, and has both functionality and beauty.

本发明和已有技术相比,其技术进步是显著的。本发明为烟酰胺的包覆提供适合的载体,同时提高烟酰胺的稳定性、减小刺激性,进而提高烟酰胺的活性和应用广泛性,开发出具有作用性强、稳定性好、无毒无害不刺激的含烟酰胺活性物的化妆品。Compared with the prior art, the technical progress of the present invention is remarkable. The invention provides a suitable carrier for the coating of nicotinamide, improves the stability of nicotinamide, reduces irritation, further improves the activity and wide application of nicotinamide, and develops a non-toxic and strong action Harmless and non-irritating cosmetics containing niacinamide actives.

附图说明Description of drawings

图1是实施例1所得的包覆烟酰胺的多囊泡脂质体的显微镜照片Fig. 1 is the photomicrograph of the multivesicular liposomes coated with nicotinamide obtained in Example 1

具体实施方式detailed description

下面通过具体实施例并结合附图对本发明进一步阐述,但并不限制本发明。The present invention will be further described below through specific embodiments in conjunction with the accompanying drawings, but the present invention is not limited.

实施例1Example 1

一种包覆烟酰胺的多囊泡脂质体,按重量百分比计算,其原料组成及含量如下:A multivesicular liposome coated with nicotinamide, calculated by weight percentage, its raw material composition and content are as follows:

磷脂 1.0%;Phospholipids 1.0%;

中性脂质 1.0%;Neutral Lipid 1.0%;

胆固醇 1.0%;Cholesterol 1.0%;

有机溶剂 5.0%;Organic solvent 5.0%;

烟酰胺 0.01%;Niacinamide 0.01%;

亲水性乳化剂 0.1%;Hydrophilic emulsifier 0.1%;

氨基酸 0.1%;Amino acid 0.1%;

渗透压调节剂 2.0%;Osmotic pressure regulator 2.0%;

去离子水 余量;Deionized water balance;

所述的磷脂为卵磷脂;Described phospholipid is lecithin;

所述的中性油脂为三油酸甘油酯;Described neutral fat is glyceryl trioleate;

所述的有机溶剂为乙醚;Described organic solvent is ether;

所述的亲水性乳化剂为吐温80;Described hydrophilic emulsifier is Tween 80;

所述的氨基酸为赖氨酸;Described amino acid is lysine;

所述的渗透压调节剂为葡萄糖;The osmotic pressure regulator is glucose;

上述的一种包覆烟酰胺的多囊泡脂质体的制备方法,具体包括如下步骤:The above-mentioned preparation method of multivesicular liposomes coated with nicotinamide specifically comprises the following steps:

1)按重量百分比称取磷脂、中性脂质、胆固醇、有机溶剂、亲水性乳化剂、烟酰胺、氨基酸、渗透压调节剂和去离子水;1) Weighing phospholipids, neutral lipids, cholesterol, organic solvents, hydrophilic emulsifiers, nicotinamide, amino acids, osmotic pressure regulators and deionized water by weight percentage;

2)将磷脂、胆固醇和中性脂质溶于有机溶剂中,作为有机相;2) dissolving phospholipids, cholesterol and neutral lipids in an organic solvent as an organic phase;

3)配置1~100mmol/L的氨基酸溶液,将烟酰胺、30~60%的氨基酸溶液、30~60%的渗透压调节剂和30~60%的去离子水混合,作为内水相;3) Prepare 1~100mmol/L amino acid solution, mix nicotinamide, 30~60% amino acid solution, 30~60% osmotic pressure regulator and 30~60% deionized water as the inner water phase;

4)将步骤3)中所得内水相加入有机相中,以均质速度7200~30000rpm均质有机相组分,同时将内水相组分加入其中,均质1~15min,制得W/O型初乳液;4) Add the internal water phase obtained in step 3) into the organic phase, homogenize the organic phase components at a homogenization speed of 7200-30000rpm, and simultaneously add the internal water phase components, homogenize for 1-15min, and obtain W/ O-type primary emulsion;

5)将亲水性乳化剂、剩余含量的氨基酸溶液、剩余含量的渗透压调节剂和剩余含量的去离子水的混合,作为外水相;5) mixing the hydrophilic emulsifier, the remaining content of the amino acid solution, the remaining content of the osmotic pressure regulator and the remaining content of deionized water as the external water phase;

6)以均质速度7200~30000rpm均质外水相组分,同时将步骤(3)制得的W/O型初乳液组分加入其中,均质1~15min后,选择超声功率20%~30%,超声5秒停止5秒,对乳状液超声1~20min,搅拌至体系均一并自然冷却降至室温,制成W/O/W型多重乳液;6) Homogenize the outer water phase components at a homogenization speed of 7200-30000rpm, and at the same time add the W/O-type primary emulsion components prepared in step (3) to it, after homogenizing for 1-15 minutes, select the ultrasonic power of 20%- 30%, ultrasonication for 5 seconds and stop for 5 seconds, ultrasonication of the emulsion for 1 to 20 minutes, stirring until the system is uniform and cooled down to room temperature naturally to make a W/O/W multiple emulsion;

7)配置与步骤3)中浓度相同的氨基酸溶液,将得到的多重乳液分散于氨基酸溶液中,其中多重乳液与氨基酸溶液的体积比为5:1~1:5,通入氮气除去多重乳液中的有机溶剂,制得包覆烟酰胺的多囊泡脂质体悬浮液。7) Configure the amino acid solution with the same concentration as in step 3), disperse the obtained multiple emulsion in the amino acid solution, wherein the volume ratio of the multiple emulsion to the amino acid solution is 5:1 to 1:5, and pass nitrogen gas to remove the multiple emulsion Organic solvent, prepared multivesicular liposome suspension coated with nicotinamide.

实施例2Example 2

一种包覆烟酰胺的多囊泡脂质体,按重量百分比计算,其原料组成及含量如下:A multivesicular liposome coated with nicotinamide, calculated by weight percentage, its raw material composition and content are as follows:

磷脂 10.0%;Phospholipids 10.0%;

中性脂质 5.0%;Neutral lipid 5.0%;

胆固醇 5.0%;Cholesterol 5.0%;

有机溶剂 12.5%;Organic solvent 12.5%;

烟酰胺 2.5%;Niacinamide 2.5%;

亲水性乳化剂 6.0%;Hydrophilic emulsifier 6.0%;

氨基酸 0.5%;Amino acid 0.5%;

渗透压调节剂 5.0%;Osmotic pressure regulator 5.0%;

去离子水 余量;Deionized water balance;

所述的磷脂为氢化卵磷脂、大豆卵磷脂中的一种或两种组成的混合物;The phospholipid is one or a mixture of hydrogenated lecithin and soybean lecithin;

所述的中性物质为甘油酸;Described neutral substance is glyceric acid;

所述的有机溶剂为乙醇;Described organic solvent is ethanol;

所述的亲水性乳化剂为聚氧乙烯-聚氧丙烯嵌段共聚物、PEG-100硬脂酸酯中的一种或两种所组成的混合物;The hydrophilic emulsifier is one or a mixture of polyoxyethylene-polyoxypropylene block copolymer and PEG-100 stearate;

所述的氨基酸为天门冬氨酸;The amino acid is aspartic acid;

所述的渗透压调节剂为蔗糖;The osmotic pressure regulator is sucrose;

上述的一种包覆烟酰胺的多囊泡脂质体的制备方法,具体包括如下步骤:The above-mentioned preparation method of multivesicular liposomes coated with nicotinamide specifically comprises the following steps:

1)按重量百分比称取磷脂、中性脂质、胆固醇、有机溶剂、亲水性乳化剂、烟酰胺、氨基酸、渗透压调节剂和去离子水;1) Weighing phospholipids, neutral lipids, cholesterol, organic solvents, hydrophilic emulsifiers, nicotinamide, amino acids, osmotic pressure regulators and deionized water by weight percentage;

2)将磷脂、胆固醇和中性脂质溶于有机溶剂中,作为有机相;2) dissolving phospholipids, cholesterol and neutral lipids in an organic solvent as an organic phase;

3)配置1~100mmol/L的氨基酸溶液,将烟酰胺、30~60%的氨基酸溶液、30~60%的渗透压调节剂和30~60%的去离子水混合,作为内水相;3) Prepare 1~100mmol/L amino acid solution, mix nicotinamide, 30~60% amino acid solution, 30~60% osmotic pressure regulator and 30~60% deionized water as the inner water phase;

4)将步骤3)中所得内水相加入有机相中,以均质速度7200~30000rpm均质有机相组分,同时将内水相组分加入其中,均质1~15min,制得W/O型初乳液;4) Add the internal water phase obtained in step 3) into the organic phase, homogenize the organic phase components at a homogenization speed of 7200-30000rpm, and simultaneously add the internal water phase components, homogenize for 1-15min, and obtain W/ O-type primary emulsion;

5)将亲水性乳化剂、剩余含量的氨基酸溶液、剩余含量的渗透压调节剂和剩余含量的去离子水的混合,作为外水相;5) mixing the hydrophilic emulsifier, the remaining content of the amino acid solution, the remaining content of the osmotic pressure regulator and the remaining content of deionized water as the external water phase;

6)以均质速度7200~30000rpm均质外水相组分,同时将步骤(3)制得的W/O型初乳液组分加入其中,均质1~15min后,选择超声功率20%~30%,超声5秒停止5秒,对乳状液超声1~20min,搅拌至体系均一并自然冷却降至室温,制成W/O/W型多重乳液;6) Homogenize the outer water phase components at a homogenization speed of 7200-30000rpm, and at the same time add the W/O-type primary emulsion components prepared in step (3) to it. After homogenizing for 1-15 minutes, select the ultrasonic power of 20%- 30%, ultrasonication for 5 seconds and stop for 5 seconds, ultrasonication of the emulsion for 1 to 20 minutes, stirring until the system is uniform and cooled down to room temperature naturally to make a W/O/W multiple emulsion;

7)配置与步骤3)中浓度相同的氨基酸溶液,将得到的多重乳液分散于氨基酸溶液中,其中多重乳液与氨基酸溶液的体积比为5:1~1:5,通入氮气除去多重乳液中的有机溶剂,制得包覆烟酰胺的多囊泡脂质体悬浮液。7) Configure the amino acid solution with the same concentration as in step 3), disperse the obtained multiple emulsion in the amino acid solution, wherein the volume ratio of the multiple emulsion to the amino acid solution is 5:1 to 1:5, and pass nitrogen gas to remove the multiple emulsion Organic solvent, prepared multivesicular liposome suspension coated with nicotinamide.

实施例3Example 3

一种包覆烟酰胺的多囊泡脂质体,按重量百分比计算,其原料组成及含量如下:A multivesicular liposome coated with nicotinamide, calculated by weight percentage, its raw material composition and content are as follows:

磷脂 20.0%;Phospholipids 20.0%;

中性脂质 10.0%;Neutral Lipid 10.0%;

胆固醇 10.0%;Cholesterol 10.0%;

有机溶剂 20.0%;Organic solvent 20.0%;

烟酰胺 5.0%;Niacinamide 5.0%;

亲水性乳化剂 12.0%;Hydrophilic emulsifier 12.0%;

氨基酸 1.0%;Amino acid 1.0%;

渗透压调节剂 8.0%;Osmotic pressure regulator 8.0%;

去离子水 14.0%;Deionized water 14.0%;

所述的磷酸为磷脂酰乙醇胺;Described phosphoric acid is phosphatidylethanolamine;

所述的中性脂质为三辛酸甘油酯、维生素E中的一种或两种所组成的混合物;The neutral lipid is one or a mixture of tricaprylin and vitamin E;

所述的有机溶剂为丁醇;Described organic solvent is butanol;

所述的亲水性乳化剂为肽类双分子亲油亲水表活、鲸蜡硬脂醇和鲸蜡硬脂基葡糖苷中的一种或两种组成的混合物;The hydrophilic emulsifier is one or a mixture of peptide bimolecular lipophilic and hydrophilic surfactants, cetearyl alcohol and cetearyl glucoside;

所述的氨基酸为L-精氨酸;The amino acid is L-arginine;

所述的渗透压调节剂为生理盐水;Described osmotic pressure regulator is physiological saline;

上述的一种包覆烟酰胺的多囊泡脂质体的制备方法,具体包括如下步骤:The above-mentioned preparation method of multivesicular liposomes coated with nicotinamide specifically comprises the following steps:

1)按重量百分比称取磷脂、中性脂质、胆固醇、有机溶剂、亲水性乳化剂、烟酰胺、氨基酸、渗透压调节剂和去离子水;1) Weighing phospholipids, neutral lipids, cholesterol, organic solvents, hydrophilic emulsifiers, nicotinamide, amino acids, osmotic pressure regulators and deionized water by weight percentage;

2)将磷脂、胆固醇和中性脂质溶于有机溶剂中,作为有机相;2) dissolving phospholipids, cholesterol and neutral lipids in an organic solvent as an organic phase;

3)配置1~100mmol/L的氨基酸溶液,将烟酰胺、30~60%的氨基酸溶液、30~60%的渗透压调节剂和30~60%的去离子水混合,作为内水相;3) Prepare 1~100mmol/L amino acid solution, mix nicotinamide, 30~60% amino acid solution, 30~60% osmotic pressure regulator and 30~60% deionized water as the inner water phase;

4)将步骤3)中所得内水相加入有机相中,以均质速度7200~30000rpm均质有机相组分,同时将内水相组分加入其中,均质1~15min,制得W/O型初乳液;4) Add the internal water phase obtained in step 3) into the organic phase, homogenize the organic phase components at a homogenization speed of 7200-30000rpm, and simultaneously add the internal water phase components, homogenize for 1-15min, and obtain W/ O-type primary emulsion;

5)将亲水性乳化剂、剩余含量的氨基酸溶液、剩余含量的渗透压调节剂和剩余含量的去离子水的混合,作为外水相;5) mixing the hydrophilic emulsifier, the remaining content of the amino acid solution, the remaining content of the osmotic pressure regulator and the remaining content of deionized water as the external water phase;

6)以均质速度7200~30000rpm均质外水相组分,同时将步骤(3)制得的W/O型初乳液组分加入其中,均质1~15min后,选择超声功率20%~30%,超声5秒停止5秒,对乳状液超声1~20min,搅拌至体系均一并自然冷却降至室温,制成W/O/W型多重乳液;6) Homogenize the outer water phase components at a homogenization speed of 7200-30000rpm, and at the same time add the W/O-type primary emulsion components prepared in step (3) to it. After homogenizing for 1-15 minutes, select the ultrasonic power of 20%- 30%, ultrasonication for 5 seconds and stop for 5 seconds, ultrasonication of the emulsion for 1 to 20 minutes, stirring until the system is uniform and cooled down to room temperature naturally to make a W/O/W multiple emulsion;

7)配置与步骤3)中浓度相同的氨基酸溶液,将得到的多重乳液分散于氨基酸溶液中,其中多重乳液与氨基酸溶液的体积比为5:1~1:5,通入氮气除去多重乳液中的有机溶剂,制得包覆烟酰胺的多囊泡脂质体悬浮液。7) Configure the amino acid solution with the same concentration as in step 3), disperse the obtained multiple emulsion in the amino acid solution, wherein the volume ratio of the multiple emulsion to the amino acid solution is 5:1 to 1:5, and pass nitrogen gas to remove the multiple emulsion Organic solvent, prepared multivesicular liposome suspension coated with nicotinamide.

上述内容仅为本发明构思下的基本说明,而依据本发明的技术方案所作的任何等效变换,均应属于本发明的保护范围。The above content is only a basic description of the concept of the present invention, and any equivalent transformation made according to the technical solution of the present invention shall belong to the protection scope of the present invention.

Claims (5)

1. a kind of many vesicles of cladding niacinamide, it is characterised in that count by weight percentage, its raw material composition and contain Amount is as follows:
Phosphatidase 1 .0 ~ 20.0%;
Neutral lipid 1.0 ~ 10.0%;
Cholesterol 1.0 ~ 10.0%;
Organic solvent 5.0 ~ 20.0%;
Niacinamide 0.01 ~ 5.0%;
Hydrophilic emulsifier 0.1 ~ 12.0%;
Amino acid 0.1 ~ 1.0%;
Osmotic pressure regulator 2.0 ~ 8.0%;
Deionized water surplus;
Described phosphoric acid be lecithin, hydrolecithin, soybean lecithin, phosphatidyl-ethanolamine, DSPC, two In dimyristoylphosphatidycholine, DOPE or DPPG one or two with On the mixture that constituted;
Described neutral lipid is olein, glyceric acid, glyceryl laurate ester, decanoin, three sad glycerine One or more mixtures for being constituted in ester or vitamin E;
Described organic solvent is by one or more mixing for constituting in ether, ethanol, butanol or ethyl acetate Thing;
Described hydrophilic emulsifier is that Tween 80, polyox-yethylene-polyoxypropylene block copolymer, peptides bimolecular oleophylic are hydrophilic Table work, PEG-100 stearates, stearine, arachidic alcohol and docosyl alcohol and arachidic alcohol glucoside, cetostearyl alcohol and whale Wax stearyl glucoside, AEO(21EO), in Compritol 888 ATO or cetearyl glucoside one Plant or two or more constituted mixtures;
Described amino acid is lysine, asparatate, serine, L-arginine, alanine, L-aminobutanedioic acid, glutamic acid, sweet One or more mixture in propylhomoserin, histidine, tryptophan, tyrosine, proline, leucine or valine;
Described osmotic pressure regulator is one or more the mixture in glucose, sucrose or physiological saline.
2. many vesicles of a kind of cladding niacinamide as claimed in claim 1, it is characterised in that by weight percentage Calculate, its raw material composition and content are as follows:
Phosphatidase 1 .0%;
Neutral lipid 1.0%;
Cholesterol 1.0%;
Organic solvent 5.0%;
Niacinamide 0.01%;
Hydrophilic emulsifier 0.1%;
Amino acid 0.1%;
Osmotic pressure regulator 2.0%;
Deionized water surplus;
Described phosphatide is lecithin;
Described neutral grease is olein;
Described organic solvent is ether;
Described hydrophilic emulsifier is Tween 80;
Described amino acid is lysine;
Described osmotic pressure regulator is glucose.
3. many vesicles of a kind of cladding niacinamide as claimed in claim 1, it is characterised in that by weight percentage Calculate, its raw material composition and content are as follows:
Phosphatidase 1 0.0%;
Neutral lipid 5.0%;
Cholesterol 5.0%;
Organic solvent 12.5%;
Niacinamide 2.5%;
Hydrophilic emulsifier 6.0%;
Amino acid 0.5%;
Osmotic pressure regulator 5.0%;
Deionized water surplus;
Described phosphatide is the mixture of hydrolecithin or one or two compositions in soybean lecithin;
Described neutral substance is glyceric acid;
Described organic solvent is ethanol;
Described hydrophilic emulsifier is in polyox-yethylene-polyoxypropylene block copolymer or PEG-100 stearates Plant or two kinds of mixtures for being constituted;
Described amino acid is asparatate;
Described osmotic pressure regulator is sucrose.
4. many vesicles of a kind of cladding niacinamide as claimed in claim 1, it is characterised in that by weight percentage Calculate, its raw material composition and content are as follows:
Phosphatidase 2 0.0%
Neutral lipid 10.0%;
Cholesterol 10.0%;
Organic solvent 20.0%;
Niacinamide 5.0%;
Hydrophilic emulsifier 12.0%;
Amino acid/11 .0%;
Osmotic pressure regulator 8.0%;
Deionized water surplus;
Described phosphoric acid is phosphatidyl-ethanolamine;
Described neutral lipid is by one or two mixtures for constituting in tricaprylin, vitamin E;
Described organic solvent is butanol;
Described hydrophilic emulsifier is in the hydrophilic table work of peptides bimolecular oleophylic, cetostearyl alcohol and cetearyl glucoside One or two mixtures for being constituted;
Described amino acid is L-arginine;
Described osmotic pressure regulator is physiological saline.
5. a kind of preparation method of many vesicles of the cladding niacinamide described in claims 1,2,3 or 4, its feature exists In specifically including following steps:
1)Phosphatide, neutral lipid, cholesterol, organic solvent, hydrophilic emulsifier, niacinamide, amino are weighed by weight percentage Acid, osmotic pressure regulator and deionized water;
2)Phosphatide, cholesterol and neutral lipid are dissolved in organic solvent, as organic phase;
3)The Freamine Ⅲ of 1 ~ 100mmol/L of configuration, by niacinamide, 30 ~ 60% Freamine Ⅲ, 30 ~ 60% osmotic pressure Conditioning agent and the mixing of 30 ~ 60% deionized water, as interior water phase;
4)By step 3)Water is added in organic phase in middle gained, with homogeneous speed 7200~30000rpm homogeneous organic phase groups Point, while interior water phase components are added thereto, 1~15min of homogeneous, w/o type colostric fluid is obtained;
5)By hydrophilic emulsifier, the Freamine Ⅲ of remaining content, the osmotic pressure regulator of remaining content and remaining content The mixing of deionized water, as outer water phase;
6)With the outer water phase components of homogeneous 7200~30000rpm of speed homogeneous, while by step(3)Obtained w/o type colostric fluid group Point be added thereto, after 1~15min of homogeneous, select ultrasonic power 20%~30%, ultrasound to stop 5 seconds in 5 seconds, to emulsion ultrasound 1~ 20min, stirs to system that in the lump natural cooling is down to room temperature, makes W/O/W type multiple emulsions;
7)Configuration with step 3) in concentration identical Freamine Ⅲ, the multiple emulsion for obtaining is scattered in Freamine Ⅲ, Wherein multiple emulsion and the volume ratio of Freamine Ⅲ are 5:1~1:5, the organic solvent that nitrogen is removed in multiple emulsion is passed through, Many vesicles suspension of cladding niacinamide are obtained.
CN201710050472.1A 2017-01-23 2017-01-23 Method for preparing nicotinamide-coated multivesicular liposomes Pending CN106619149A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201710050472.1A CN106619149A (en) 2017-01-23 2017-01-23 Method for preparing nicotinamide-coated multivesicular liposomes

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201710050472.1A CN106619149A (en) 2017-01-23 2017-01-23 Method for preparing nicotinamide-coated multivesicular liposomes

Publications (1)

Publication Number Publication Date
CN106619149A true CN106619149A (en) 2017-05-10

Family

ID=58842135

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201710050472.1A Pending CN106619149A (en) 2017-01-23 2017-01-23 Method for preparing nicotinamide-coated multivesicular liposomes

Country Status (1)

Country Link
CN (1) CN106619149A (en)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107308454A (en) * 2017-06-21 2017-11-03 广州市禾基生物科技有限公司 Liposome and its preparation method and application
CN109106657A (en) * 2018-11-08 2019-01-01 妃瑶生物科技(上海)有限公司 A kind of prinsepia utilis royle oil liposome and preparation method thereof
CN110812254A (en) * 2019-07-08 2020-02-21 圣菲之美(湖北)生物科技有限公司 Phospholipase-coated multivesicular liposome and preparation method and application thereof
CN113827498A (en) * 2020-06-24 2021-12-24 南京理工大学 Preparation method of nicotinamide liposome
CN113876642A (en) * 2021-11-12 2022-01-04 湖北省麦诗特生物科技有限公司 Cream composition containing lipid nanoparticles with moisturizing and hydrating effects and preparation method thereof
CN114514012A (en) * 2019-10-15 2022-05-17 株式会社高丝 External preparation for skin
US11617706B2 (en) 2020-06-29 2023-04-04 The Procter & Gamble Company Hair conditioning composition free of fatty alcohol

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1875916A (en) * 2006-04-27 2006-12-13 广州市采诗化妆品有限公司 A whitening moisturizing composition
CN101780039A (en) * 2010-03-05 2010-07-21 南京海陵中药制药工艺技术研究有限公司 Tramadol multivesicular liposome and preparation method thereof
CN102274183A (en) * 2010-06-13 2011-12-14 上海现代药物制剂工程研究中心有限公司 Preparation method and application of multi-vesicular liposome
CN103432009A (en) * 2013-09-12 2013-12-11 广东轻工职业技术学院 Whitening agent liposome coating micro-capsule composition as well as preparation method and application thereof
CN103932909A (en) * 2014-04-25 2014-07-23 北京博辉瑞进生物科技有限公司 Composition for facial care and preparation method of composition
CN105534905A (en) * 2015-12-28 2016-05-04 正大天晴药业集团股份有限公司 Multi-vesicular liposome containing entecavir and preparation method of multi-vesicular liposome

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1875916A (en) * 2006-04-27 2006-12-13 广州市采诗化妆品有限公司 A whitening moisturizing composition
CN101780039A (en) * 2010-03-05 2010-07-21 南京海陵中药制药工艺技术研究有限公司 Tramadol multivesicular liposome and preparation method thereof
CN102274183A (en) * 2010-06-13 2011-12-14 上海现代药物制剂工程研究中心有限公司 Preparation method and application of multi-vesicular liposome
CN102274183B (en) * 2010-06-13 2013-08-28 上海现代药物制剂工程研究中心有限公司 Preparation method and application of multi-vesicular liposome
CN103432009A (en) * 2013-09-12 2013-12-11 广东轻工职业技术学院 Whitening agent liposome coating micro-capsule composition as well as preparation method and application thereof
CN103932909A (en) * 2014-04-25 2014-07-23 北京博辉瑞进生物科技有限公司 Composition for facial care and preparation method of composition
CN105534905A (en) * 2015-12-28 2016-05-04 正大天晴药业集团股份有限公司 Multi-vesicular liposome containing entecavir and preparation method of multi-vesicular liposome
CN105534905B (en) * 2015-12-28 2017-03-15 正大天晴药业集团股份有限公司 A kind of multivesicular liposome containing Entecavir and preparation method thereof

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107308454A (en) * 2017-06-21 2017-11-03 广州市禾基生物科技有限公司 Liposome and its preparation method and application
CN109106657A (en) * 2018-11-08 2019-01-01 妃瑶生物科技(上海)有限公司 A kind of prinsepia utilis royle oil liposome and preparation method thereof
CN110812254A (en) * 2019-07-08 2020-02-21 圣菲之美(湖北)生物科技有限公司 Phospholipase-coated multivesicular liposome and preparation method and application thereof
CN114514012A (en) * 2019-10-15 2022-05-17 株式会社高丝 External preparation for skin
CN113827498A (en) * 2020-06-24 2021-12-24 南京理工大学 Preparation method of nicotinamide liposome
US11617706B2 (en) 2020-06-29 2023-04-04 The Procter & Gamble Company Hair conditioning composition free of fatty alcohol
US11969490B2 (en) 2020-06-29 2024-04-30 The Procter & Gamble Company Hair conditioning composition with antimicrobial system
CN113876642A (en) * 2021-11-12 2022-01-04 湖北省麦诗特生物科技有限公司 Cream composition containing lipid nanoparticles with moisturizing and hydrating effects and preparation method thereof
CN113876642B (en) * 2021-11-12 2023-10-20 湖北省麦诗特生物科技有限公司 A facial cream composition containing lipid nanoparticle with moisturizing effect and its preparation method

Similar Documents

Publication Publication Date Title
CN106619149A (en) Method for preparing nicotinamide-coated multivesicular liposomes
Kim et al. Transdermal delivery systems in cosmetics
JP4758915B2 (en) Multilamellar liposome and production method thereof
CN106726640A (en) Ascorbic many vesicles of one kind cladding and preparation method thereof
JP3411570B2 (en) Blended lipid vesicles
Gupta et al. Glycerosomes: Advanced Liposomal Drug Delivery System.
JP2003327526A (en) Liposome increased with percentage of enclosed compound
CN113116824A (en) Nano liposome and preparation method and application thereof
WO2009142018A1 (en) Method for producing vesicle, vesicle obtained by the production method, and w/o/w emulsion for producing vesicle
CN106726643A (en) A kind of many vesicles for coating water-soluble glabridin and preparation method thereof
WO2010104128A1 (en) Ph-responsive liposome
KR100823345B1 (en) Silica Carrying Nano-Sized Liposomal Emulsion Containing Coenzyme Kyuten and Method for Preparing the Same
CN106726641A (en) A kind of many vesicles of cladding D panthenols and preparation method thereof
CN105213207B (en) A kind of non-phospholipid surfactants multiplet liposome and preparation method thereof
EP0521562A1 (en) Vesicles in non-polar media
JP2016084340A (en) Skin external preparation and skin barrier function improving agent
CN106726642A (en) A kind of preparation method of many vesicles for coating OPC
JPH07112969B2 (en) Alcohol-containing aqueous gel phospholipid composition, method for producing liposome solution for diluting the phospholipid composition, and topical preparation containing the phospholipid composition
JP7740933B2 (en) Liposome-containing composition for cosmetics, and cosmetics
JP4842553B2 (en) Method for stabilizing nano-emulsified particles using hydroxycarboxylic acid ester and external preparation for skin containing nano-emulsified particles
AU2019291580B2 (en) Process for formation of emulsion containing liquid crystal structure
KR19990058599A (en) Cosmetic composition containing a double capsule
CN110652460B (en) Compositions containing linoleic acid
CN116785182B (en) Vesicle for wrapping active substances, preparation method and application thereof
RU2806276C2 (en) Method of production of emulsion with a liquid crystal structure

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20170510

WD01 Invention patent application deemed withdrawn after publication